Synergistic Effect of Diosmin and Interferon-α on Metastatic Pulmonary Melanoma

被引:15
作者
Alvarez, Nuria [1 ]
Vicente, Vicente [1 ]
Martinez, Cristina [2 ]
机构
[1] Univ Murcia, Fac Med, Dept Pathol, Inst Res Aging, E-30100 Murcia, Spain
[2] Inst Murciano Invest & Desarrollo Agr & Alimentar, Dept Human Resources & Rural Dev, Murcia, Spain
关键词
diosmin; flavonoid; interferon alpha; lung; melanoma; metastasis; DAFLON; 500; MG; NATURALLY-OCCURRING FLAVONOIDS; MALIGNANT-MELANOMA; IFN-ALPHA; CELL CARCINOMA; IN-VITRO; INHIBITION; EXPRESSION; PATHWAYS; BLADDER;
D O I
10.1089/cbr.2008.0565
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Melanoma is the most important skin cancer in terms of mortality, besides developing metastasis in about a third of the patients. Interferon-alpha (IFN-alpha), a highly toxic cytokine, tends to be one of the most important treatments for melanoma. Much effort is being directed at obtaining less-toxic antitumoral compounds, particularly natural compounds such as flavonoids. Our aim was to study the combined treatment of metastatic lung melanoma with IFN-alpha and diosmin in a murine model. In this article, we report the effect of a combined treatment of IFN-alpha and the flavonoid, diosmin, on a murine model of metastatic B16F10 melanoma, assessed both macroscopically (counting subpleural nodules) and microscopically by image analysis (calculating three indices). IFN-alpha showed a dose-dependent anti-invasive and antiproliferative activity in our study, while diosmin showed an anti-invasive activity similar to the lower dose of IFN-alpha used. However, the most relevant result was the synergistic antiproliferative effect shown by the combination of the flavonoid and the lowest dose of IFN-alpha, which was similar to that produced by the highest dose of the cytokine alone.
引用
收藏
页码:347 / 352
页数:6
相关论文
共 43 条
  • [1] [Anonymous], CLIN TRANSL ONCOL
  • [2] Avnet S, 2007, INT J ONCOL, V30, P469
  • [3] Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
    Balch, CM
    Buzaid, AC
    Soong, SJ
    Atkins, MB
    Cascinelli, N
    Coit, DG
    Fleming, ID
    Gershenwald, JE
    Houghton, A
    Kirkwood, JM
    McMasters, KM
    Mihm, MF
    Morton, DL
    Reintgen, DS
    Ross, MI
    Sober, A
    Thompson, JA
    Thompson, JF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3635 - 3648
  • [4] Bear WL, 2000, ANTICANCER RES, V20, P3609
  • [5] Interferon-alpha in tumor immunity and immunotherapy
    Belardelli, F
    Ferrantini, M
    Proietti, E
    Kirkwood, JM
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) : 119 - 134
  • [6] Ethanol modulates metastatic potential of B16BL6 melanoma and host responses
    Blank, SE
    Meadows, GG
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1996, 20 (04) : 624 - 628
  • [7] Antiproliferative activity of various flavonoids and related compounds:: additive effect of interferon-α2b
    Blank, VC
    Poll, C
    Marder, M
    Roguin, LP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 133 - 136
  • [8] Interferon-α inhibits cyclooxygenase-1 and stimulates cyclooxygenase-2 expression in bladder cancer cells in vitro
    Boström, PJ
    Uotila, P
    Rajala, P
    Nurmi, M
    Huhtaniemi, I
    Laato, M
    [J]. UROLOGICAL RESEARCH, 2001, 29 (01): : 20 - 24
  • [9] Alpha-interferon and its effects on signal transduction pathways
    Caraglia, M
    Marra, M
    Pelaia, G
    Maselli, R
    Caputi, M
    Marsico, SA
    Abbruzzese, A
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 202 (02) : 323 - 335
  • [10] Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids:: Analysis of the structure-activity relationship
    Comalada, Monica
    Ballester, Isabel
    Bailon, Elvira
    Xaus, Jordi
    Galvez, Julio
    Sanchez de Medina, Fermin
    Zarzuelo, Antonio
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 72 (08) : 1010 - 1021